(Q38366716)

2 September 2017

1 reference

title

Effect of neuroleptics on positive and negative symptoms and the deficit state (English)

1 reference

2 September 2017

Angst J

1

1 reference

2 September 2017

Stassen HH

series ordinal

2

1 reference

2 September 2017

Woggon B

series ordinal

3

1 reference

2 September 2017

publication date

1 January 1989

1 reference

2 September 2017

1 reference

2 September 2017

volume

99 Suppl

1 reference

2 September 2017

page(s)

S41-6

1 reference

A Negative Symptom Rating Scale

2 September 2017

cites work

1 reference

12 December 2020

[Depressive states in schizophrenic in-patients on admission and at discharge (author's transl)]

1 reference

12 December 2020

An empirical test of a Kraepelinian vs. a Bleulerian view of negative symptoms.

1 reference

12 December 2020

The AMDP-system in chronic hospitalized schizophrenics

1 reference

12 December 2020

[Neurotic and endogenous residual states]

1 reference

12 December 2020

Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality

1 reference

12 December 2020

Neuroleptic-induced parkinsonism in older schizophrenics

1 reference

12 December 2020

Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.

1 reference

12 December 2020

Negative and deficit symptoms in schizophrenia do respond to neuroleptics

1 reference

12 December 2020

Akathisia variants and tardive dyskinesia

1 reference

12 December 2020

The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia

1 reference

12 December 2020

The two-syndrome concept: origins and current status

1 reference

12 December 2020

Lifestyle and age of schizophrenics. A catamnestic long-term study into old age

1 reference

12 December 2020

Negative symptoms: are they indigenous to schizophrenia?

1 reference

12 December 2020

Treatment of negative symptoms

1 reference

12 December 2020

Negative v positive schizophrenia. Definition and validation.

1 reference

12 December 2020

Measurement of negative symptoms

1 reference

12 December 2020

"Negative symptoms": conceptual and methodological problems

1 reference

12 December 2020

The positive-negative dimension in schizophrenia: its validity and significance.

1 reference

12 December 2020

Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients

1 reference

12 December 2020

Validity of the AMP-System for its use in clinical psychopharmacology.

1 reference

12 December 2020

The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs.

1 reference

12 December 2020

Assessment of negative and positive symptoms in schizophrenia

1 reference

12 December 2020

On the problem of the process of schizophrenia under drug therapy

1 reference

12 December 2020

Negative symptoms in schizophrenia. Definition and reliability

1 reference

12 December 2020

Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics

1 reference

12 December 2020

[On the significance of post-remissive exhaustion-syndrome for the rehabilitation of schizophrenics]

1 reference

12 December 2020

Huber's basic symptoms: another approach to negative psychopathology in schizophrenia

1 reference

12 December 2020

Late onset involuntary movements in chronic schizophrenia: relationship of 'tardive' dyskinesia to intellectual impairment and negative symptoms

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00442558

1 reference

Dimensions Publication ID

2 September 2017

1050602844

0 references

1 reference